PMC:7536913 / 12633-13254 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":333,"end":337},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"POTENTIAL CHALLENGES\nThese proposals are not without their respective challenges. Technological solutions need to account for issues like privacy, security, and platform stability; likewise, expanded training for personnel might also be necessary. Unintended consequences can also result, e.g., the possible development of diverging drug review processes under various global health authorities. But these challenges can be addressed and overcome. Considering the significant benefit these transformative initiatives bring to patients, we support near‐term implementation with reviews and future adjustments as necessary."}

{"project":"LitCovid-PubTator","denotations":[{"id":"105","span":{"begin":10,"end":20},"obj":"Disease"},{"id":"107","span":{"begin":526,"end":534},"obj":"Species"}],"attributes":[{"id":"A107","pred":"tao:has_database_id","subj":"107","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"POTENTIAL CHALLENGES\nThese proposals are not without their respective challenges. Technological solutions need to account for issues like privacy, security, and platform stability; likewise, expanded training for personnel might also be necessary. Unintended consequences can also result, e.g., the possible development of diverging drug review processes under various global health authorities. But these challenges can be addressed and overcome. Considering the significant benefit these transformative initiatives bring to patients, we support near‐term implementation with reviews and future adjustments as necessary."}

{"project":"LitCovid-sentences","denotations":[{"id":"T81","span":{"begin":0,"end":20},"obj":"Sentence"},{"id":"T82","span":{"begin":21,"end":81},"obj":"Sentence"},{"id":"T83","span":{"begin":82,"end":247},"obj":"Sentence"},{"id":"T84","span":{"begin":248,"end":395},"obj":"Sentence"},{"id":"T85","span":{"begin":396,"end":447},"obj":"Sentence"},{"id":"T86","span":{"begin":448,"end":621},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"POTENTIAL CHALLENGES\nThese proposals are not without their respective challenges. Technological solutions need to account for issues like privacy, security, and platform stability; likewise, expanded training for personnel might also be necessary. Unintended consequences can also result, e.g., the possible development of diverging drug review processes under various global health authorities. But these challenges can be addressed and overcome. Considering the significant benefit these transformative initiatives bring to patients, we support near‐term implementation with reviews and future adjustments as necessary."}